FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions relates to the pharmaceutical industry, in particular to a biodegradable transmucosal delivery system comprising a complex of drotaverine or a pharmaceutically acceptable salt thereof and a taste masking agent, such as cyclodextrin, in a weight ratio of 1:10 to 10:1 and one or more auxiliary components providing a form suitable for application on the oral mucosa, where drotaverine or its pharmaceutically acceptable salt is present in a therapeutically effective amount. Invention also discloses: a method of making said system, as well as a method for transmucosal delivery of drotaverine into an individual's body by superimposing said system on a mucosal surface of the oral cavity.
EFFECT: group of inventions widens the range of drug preparations with drotaverine in the form of a transmucosal delivery system having good taste properties.
8 cl, 2 ex, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
DOSAGE FORM FOR RELEASING DROTAVERINE IN ORAL CAVITY | 2019 |
|
RU2729659C1 |
PHARMACEUTICAL COMPOSITION INCLUDING DICLOFENAC | 2005 |
|
RU2424793C2 |
OROMUCOUS NANOFIBER CARRIERS FOR THERAPEUTIC TREATMENT | 2017 |
|
RU2751508C2 |
LAMINAR DRUG DELIVERY DEVICE | 2011 |
|
RU2594064C2 |
METHOD FOR TRANSMUCOSAL DRUG DELIVERY, AGENT FOR TRANSMUCOSAL DRUG DELIVERY (VERSIONS) AND METHOD FOR PAIN MANAGEMENT | 2007 |
|
RU2504377C2 |
PHARMACEUTICAL COMPOSITION FOR ORAL APPLICATION AND METHOD OF ITS PREPARATION | 2005 |
|
RU2342936C2 |
NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
PREPARATIONS OF THERMO-ABRASIVE HYDROGEL FOR APPLICATION IN TREATMENT OF UTERTAL DISORDERS | 2013 |
|
RU2635466C2 |
UNSPITTABLE QUICKLY DECOMPOSING NEUROLEPTIC-CONTAINING FILM FOR ORAL APPLICATION | 2006 |
|
RU2427374C2 |
RAPIDLY DISSOLVING MEDICATION-RELEASING SYSTEMS | 2011 |
|
RU2560693C2 |
Authors
Dates
2019-09-11—Published
2017-12-05—Filed